Global Skin Barrier Market
Global Skin Barrier Market

Skin Barrier Comprehensive Study by Shape (Flat, Convex), Surgery (Colostomy, Ileostomy, Urostomy)

Skin Barrier Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2021 Edition 222 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Skin Barrier Market Overview:
Skin barriers are preferred for wound care management, incontinence, and ostomy care management. A skin barrier adheres to peristomal skin, which helps to protect the skin from stoma output by attaching the pouch to the body. These barriers help patients suffering from fecal incontinence by keeping the skin free of contaminants. . This scenario depicts that the global skin barriers market will witness promising growth opportunities in the forthcoming years. Owing to the ability of skin barriers to adhering to peristomal skin, they assist in protecting the skin from stoma.

Growth Drivers
  • Increased Cases of Many Autoimmune Diseases including Irritable Bowel Disease
  • Surge in Geriatric Population across the Globe

Market Trends
  • Increase in Research Activities for the Development of Medical Devices

Roadblocks
  • High Cost of Skin Barriers
  • Increased Cases of Allergies owing to Skin Barrier Materials

Opportunities
  • Major Players are Investing Heavily in the Research and Development Activities
  • High Growth Potential in Emerging Economies
  • Rise in Government Initiatives for the Improvement of the Healthcare Sector

Challenges
  • Dearth of Skilled Professionals


Competitive Landscape:
The rising number of players expected to enter the global market is predicted to enhance the competition level as well as encourage the growth of the overall market in the near future. Players are anticipated to focus on the development of new compounds, which is likely to encourage the growth of the global market throughout the forecast period.
Some of the key players profiled in the report are 3M Company (United States), B. Braun Melsungen AG (Germany), Coloplast Corp (United States), ConvaTec Group PLC (United Kingdom), Cymed Healthcare (United States), Hollister Inc. (United States), Marlen Manufacturing & Development Co.(United States), Nu-Hope Laboratories, Inc. (United States), Safe ní Simple Medical (United States) and Torbot Group, Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Skin Barrier market by 2026. Considering Market by Shape, the sub-segment i.e. Flat will boost the Skin Barrier market. Considering Market by Surgery, the sub-segment i.e. Colostomy will boost the Skin Barrier market.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Skin Barrier market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Skin Barrier market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Shape
  • Flat
  • Convex

By Surgery
  • Colostomy
  • Ileostomy
  • Urostomy

By Regions
    • 1. Market Overview
      • 1.1. Introduction
      • 1.2. Scope/Objective of the Study
        • 1.2.1. Research Objective
    • 2. Executive Summary
      • 2.1. Introduction
    • 3. Market Dynamics
      • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. Increased Cases of Many Autoimmune Diseases including Irritable Bowel Disease
        • 3.2.2. Surge in Geriatric Population across the Globe
      • 3.3. Market Challenges
        • 3.3.1. Dearth of Skilled Professionals
      • 3.4. Market Trends
        • 3.4.1. Increase in Research Activities for the Development of Medical Devices
    • 4. Market Factor Analysis
      • 4.1. Porters Five Forces
      • 4.2. Supply/Value Chain
      • 4.3. PESTEL analysis
      • 4.4. Market Entropy
      • 4.5. Patent/Trademark Analysis
    • 5. Global Skin Barrier, by Shape and Surgery (value and price ) (2015-2020)
      • 5.1. Introduction
      • 5.2. Global Skin Barrier (Value)
        • 5.2.1. Global Skin Barrier by: Shape (Value)
          • 5.2.1.1. Flat
          • 5.2.1.2. Convex
        • 5.2.2. Global Skin Barrier by: Surgery (Value)
          • 5.2.2.1. Colostomy
          • 5.2.2.2. Ileostomy
          • 5.2.2.3. Urostomy
      • 5.3. Global Skin Barrier (Price)
    • 6. Skin Barrier: Manufacturers/Players Analysis
      • 6.1. Competitive Landscape
        • 6.1.1. Market Share Analysis
          • 6.1.1.1. Top 3
          • 6.1.1.2. Top 5
      • 6.2. Peer Group Analysis (2020)
      • 6.3. BCG Matrix
      • 6.4. Company Profile
        • 6.4.1. 3M Company (United States)
          • 6.4.1.1. Business Overview
          • 6.4.1.2. Products/Services Offerings
          • 6.4.1.3. Financial Analysis
          • 6.4.1.4. SWOT Analysis
        • 6.4.2. B. Braun Melsungen AG (Germany)
          • 6.4.2.1. Business Overview
          • 6.4.2.2. Products/Services Offerings
          • 6.4.2.3. Financial Analysis
          • 6.4.2.4. SWOT Analysis
        • 6.4.3. Coloplast Corp (United States)
          • 6.4.3.1. Business Overview
          • 6.4.3.2. Products/Services Offerings
          • 6.4.3.3. Financial Analysis
          • 6.4.3.4. SWOT Analysis
        • 6.4.4. ConvaTec Group PLC (United Kingdom)
          • 6.4.4.1. Business Overview
          • 6.4.4.2. Products/Services Offerings
          • 6.4.4.3. Financial Analysis
          • 6.4.4.4. SWOT Analysis
        • 6.4.5. Cymed Healthcare (United States)
          • 6.4.5.1. Business Overview
          • 6.4.5.2. Products/Services Offerings
          • 6.4.5.3. Financial Analysis
          • 6.4.5.4. SWOT Analysis
        • 6.4.6. Hollister Inc. (United States)
          • 6.4.6.1. Business Overview
          • 6.4.6.2. Products/Services Offerings
          • 6.4.6.3. Financial Analysis
          • 6.4.6.4. SWOT Analysis
        • 6.4.7. Marlen Manufacturing & Development Co.(United States)
          • 6.4.7.1. Business Overview
          • 6.4.7.2. Products/Services Offerings
          • 6.4.7.3. Financial Analysis
          • 6.4.7.4. SWOT Analysis
        • 6.4.8. Nu-Hope Laboratories, Inc. (United States)
          • 6.4.8.1. Business Overview
          • 6.4.8.2. Products/Services Offerings
          • 6.4.8.3. Financial Analysis
          • 6.4.8.4. SWOT Analysis
        • 6.4.9. Safe ní Simple Medical (United States)
          • 6.4.9.1. Business Overview
          • 6.4.9.2. Products/Services Offerings
          • 6.4.9.3. Financial Analysis
          • 6.4.9.4. SWOT Analysis
        • 6.4.10. Torbot Group, Inc. (United States)
          • 6.4.10.1. Business Overview
          • 6.4.10.2. Products/Services Offerings
          • 6.4.10.3. Financial Analysis
          • 6.4.10.4. SWOT Analysis
    • 7. Global Skin Barrier Sale, by Shape and Surgery (value and price ) (2021-2026)
      • 7.1. Introduction
      • 7.2. Global Skin Barrier (Value)
        • 7.2.1. Global Skin Barrier by: Shape (Value)
          • 7.2.1.1. Flat
          • 7.2.1.2. Convex
        • 7.2.2. Global Skin Barrier by: Surgery (Value)
          • 7.2.2.1. Colostomy
          • 7.2.2.2. Ileostomy
          • 7.2.2.3. Urostomy
      • 7.3. Global Skin Barrier (Price)
    • 8. Appendix
      • 8.1. Acronyms
    • 9. Methodology and Data Source
      • 9.1. Methodology/Research Approach
        • 9.1.1. Research Programs/Design
        • 9.1.2. Market Size Estimation
        • 9.1.3. Market Breakdown and Data Triangulation
      • 9.2. Data Source
        • 9.2.1. Secondary Sources
        • 9.2.2. Primary Sources
      • 9.3. Disclaimer
    List of Tables
    • Table 1. Skin Barrier: by Shape(USD Million)
    • Table 2. Skin Barrier: by Surgery(USD Million)
    • Table 3. Company Basic Information, Sales Area and Its Competitors
    • Table 4. Company Basic Information, Sales Area and Its Competitors
    • Table 5. Company Basic Information, Sales Area and Its Competitors
    • Table 6. Company Basic Information, Sales Area and Its Competitors
    • Table 7. Company Basic Information, Sales Area and Its Competitors
    • Table 8. Company Basic Information, Sales Area and Its Competitors
    • Table 9. Company Basic Information, Sales Area and Its Competitors
    • Table 10. Company Basic Information, Sales Area and Its Competitors
    • Table 11. Company Basic Information, Sales Area and Its Competitors
    • Table 12. Company Basic Information, Sales Area and Its Competitors
    • Table 13. Skin Barrier: by Shape(USD Million)
    • Table 14. Skin Barrier: by Surgery(USD Million)
    • Table 15. Research Programs/Design for This Report
    • Table 16. Key Data Information from Secondary Sources
    • Table 17. Key Data Information from Primary Sources
    List of Figures
    • Figure 1. Porters Five Forces
    • Figure 2. Supply/Value Chain
    • Figure 3. PESTEL analysis
    • Figure 4. Global Skin Barrier: by Shape USD Million (2015-2020)
    • Figure 5. Global Skin Barrier: by Surgery USD Million (2015-2020)
    • Figure 6. Global Skin Barrier share by Players 2020 (%)
    • Figure 7. Global Skin Barrier share by Players (Top 3) 2020(%)
    • Figure 8. Global Skin Barrier share by Players (Top 5) 2020(%)
    • Figure 9. BCG Matrix for key Companies
    • Figure 10. 3M Company (United States) Revenue, Net Income and Gross profit
    • Figure 11. 3M Company (United States) Revenue: by Geography 2020
    • Figure 12. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
    • Figure 13. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
    • Figure 14. Coloplast Corp (United States) Revenue, Net Income and Gross profit
    • Figure 15. Coloplast Corp (United States) Revenue: by Geography 2020
    • Figure 16. ConvaTec Group PLC (United Kingdom) Revenue, Net Income and Gross profit
    • Figure 17. ConvaTec Group PLC (United Kingdom) Revenue: by Geography 2020
    • Figure 18. Cymed Healthcare (United States) Revenue, Net Income and Gross profit
    • Figure 19. Cymed Healthcare (United States) Revenue: by Geography 2020
    • Figure 20. Hollister Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 21. Hollister Inc. (United States) Revenue: by Geography 2020
    • Figure 22. Marlen Manufacturing & Development Co.(United States) Revenue, Net Income and Gross profit
    • Figure 23. Marlen Manufacturing & Development Co.(United States) Revenue: by Geography 2020
    • Figure 24. Nu-Hope Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 25. Nu-Hope Laboratories, Inc. (United States) Revenue: by Geography 2020
    • Figure 26. Safe ní Simple Medical (United States) Revenue, Net Income and Gross profit
    • Figure 27. Safe ní Simple Medical (United States) Revenue: by Geography 2020
    • Figure 28. Torbot Group, Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 29. Torbot Group, Inc. (United States) Revenue: by Geography 2020
    • Figure 30. Global Skin Barrier: by Shape USD Million (2021-2026)
    • Figure 31. Global Skin Barrier: by Surgery USD Million (2021-2026)
    Some of the key companies/manufacturers profiled in the report
    • 3M Company (United States)
    • B. Braun Melsungen AG (Germany)
    • Coloplast Corp (United States)
    • ConvaTec Group PLC (United Kingdom)
    • Cymed Healthcare (United States)
    • Hollister Inc. (United States)
    • Marlen Manufacturing & Development Co.(United States)
    • Nu-Hope Laboratories, Inc. (United States)
    • Safe ní Simple Medical (United States)
    • Torbot Group, Inc. (United States)
    Select License Type
    Sample Report Enquiry Before Buy Request Discount

    Speak with Analyst

    Want to find out more about this report?

    Get Free Consultation